Tag: FDA
-
OpenAI partners with FDA to develop AI for faster drug evaluations
OpenAI is in talks with the U.S. Food and Drug Administration (FDA) to explore AI use in drug evaluations. The discussions focus on a project called “cderGPT,” an AI tool designed for the FDA’s Center for Drug Evaluation (CDE). This center regulates over-the-counter and prescription drugs in the United States. The goal is to use…